What's the best Mounjaro dose for weight loss?

Mounjaro is licensed in six UK strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg — titration is built into the treatment, not optional.
The 2.5 mg starting dose is a tolerability phase; it exists to settle your system before any therapeutic step-up begins.
Higher doses consistently produced greater average weight loss in clinical trials; the 15 mg dose showed the strongest results in the SURMOUNT programme.
Your prescriber, not the dose schedule alone, determines the pace and ceiling of your titration based on how you're responding and tolerating treatment.

There is no single 'best' dose of Mounjaro for weight loss — the right dose is the highest one your body tolerates well, reached gradually through a structured titration schedule. Treatment starts at 2.5 mg and steps up every four weeks, guided by a prescriber who reviews your response at each stage. These are prescription-only medicines; a clinician decides what is appropriate for you specifically. For most adults in clinical trials, meaningful weight loss accumulated as doses increased toward the 10 mg, 12.5 mg and 15 mg range, with tirzepatide (Mounjaro) achieving average reductions of around 20–21% of body weight at the 15 mg maintenance dose in the SURMOUNT-1 trial, published in the New England Journal of Medicine.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the Mounjaro dose ladder actually works in practice

Step 1: the 2.5 mg phase is about adjustment, not results

A question our prescribers hear most weeks is some version of: 'I've been on 2.5 mg for a month and barely anything has changed, is it working?' The short answer is that it's doing exactly what it's supposed to. The first pen's job is to let your gut adapt to tirzepatide's dual GIP and GLP-1 receptor activity before you move to a dose that carries genuine therapeutic weight. Nausea and digestive discomfort are most common in the opening weeks, and starting low reduces how sharply they hit.

Four weeks in, your prescriber reviews your response. If you've tolerated the starting dose without significant problems, titration to 5 mg follows. The 5 mg pen is where most people first notice appetite beginning to shift. This is still the early part of the schedule, don't judge the treatment's potential here.

For context, the full Mounjaro dose structure for weight loss follows a standardised ladder: 2.5 mg, then 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, each typically held for around four weeks before a step up. That's a minimum of roughly six months to reach the highest licensed dose, assuming tolerability at each stage.

Step 2: where the meaningful losses accumulate, the mid-to-upper doses

Clinical trial data from SURMOUNT-1 makes the dose-response relationship clear: weight loss was greater at each successively higher dose. Adults taking 10 mg lost more on average than those on 5 mg; 15 mg produced the strongest results of all. The 15 mg dose is the licensed maximum and the one associated with approximately 20–21% average body-weight reduction over 72 weeks. NICE's appraisal of tirzepatide references this evidence directly in its recommendation, available at NICE TA1026.

This doesn't mean 15 mg is guaranteed to be your dose. Some people lose substantial weight at 10 mg and tolerate it better than the step to 12.5 mg. A prescriber will weigh your weight trajectory, side-effect burden and overall health picture before recommending any increase. Pushing to the maximum dose is not always the right clinical call.

It's worth noting that cost changes with dose too. If you want to understand how pricing shifts as the schedule progresses, the Mounjaro cost guide covers what to expect at each stage from a private clinic.

Step 3: staying at your optimal dose, or adjusting

Once you've reached a dose that's producing steady, tolerable progress, the clinical conversation shifts from 'should we go higher?' to 'is this the right place to stay?' Not everyone needs to reach 15 mg. NICE's guidance on tirzepatide suggests that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing should be reviewed, a threshold that reflects the medicine's intended purpose alongside a reduced-calorie diet and increased physical activity.

If side effects become difficult at a given dose, a prescriber may recommend holding at the previous level rather than pushing through. This is a legitimate, common outcome. What counts as the best dose is ultimately individual: it's the dose at which your weight loss is clinically meaningful and your quality of life stays intact. The 15 mg ceiling is the maximum the MHRA licence permits, no prescriber should go beyond it.

The NHS tirzepatide medicines page provides patient-level information on how tirzepatide works and what to expect during treatment, including when to contact a clinician if side effects become a concern.

What this means when you're choosing a service

The dose schedule matters when you're picking a provider because not all services handle titration with the same rigour. A legitimate, clinician-led service reviews your case before each repeat, checks that a dose increase is clinically appropriate and considers your whole picture, not just your subscription status. That clinical re-review before every order is how the way nume is set up differs from services that treat repeat supply as automatic.

If you're already on Mounjaro elsewhere and want to transfer, a prescriber here will ask for evidence of your current dose and treatment history before continuing, that's standard safe practice, not an obstacle. Common questions about transferring are covered in our FAQ section. You can explore all weight-loss treatment options before deciding, or if you're ready to have your circumstances assessed, start with a free consultation with our prescribers.

Mounjaro is a prescription-only medicine. Suitability is assessed individually; the right dose for someone else isn't the guide for yours. Start your free consultation and a GPhC-registered Independent Prescriber will review your case the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions